Clinical Trial Update: Safety Study in Adolescent and Adult Patients With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 safety study in adolescent and adult patients with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED